Efficacy of Intrauterine Lidocaine and Naproxen for Pain Control With Intrauterine Device Insertion
Completed · Not applicable · Has a placebo group
Conditions studied: Contraception, Pain
In brief
To compare the efficacy of intrauterine lidocaine and oral naproxen sodium on discomfort and pain of patients undergoing intrauterine device insertion.
Key facts
- Study ID
- NCT02769247
- Run by
- Walter Reed National Military Medical Center
- People needed
- 160
- Starts
- 2014-06-01
- Expected to finish
- 2016-12-01
- Last updated by the study team
- 2018-11-08
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- DEERS-eligible reproductive age women (i.e. Tricare beneficiaries)
- age 18 years and older
- desiring Paragard or Mirena intrauterine device insertion
You may not qualify if…
- Current pregnancy
- cervical stenosis
- severe medical illness
- known allergy or sensitivity to lidocaine or naproxen
- peptic ulcer disease
- current pelvic inflammatory disease
- patients with known renal insufficiency
- patients using chronic NSAIDs or on chronic pain medication
- women desiring Skyla IUD insertion will also be excluded due to infrequency of insertions at WRNMMC
Where it is running
- Walter Reed National Military Medical Center — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.